These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31257246)

  • 1. Human Leukocyte Antigen-Associated HIV-1 CRF02_AG gag and vif Polymorphisms in Ghana.
    Adusei-Poku MA; Matsuoka S; Bonney EY; Abana CZ; Duker EO; Nii-Trebi NI; Ofori SB; Mizutani T; Ishizaka A; Shiino T; Kawana-Tachikawa A; Ishikawa K; Ampofo WK; Matano T
    Jpn J Infect Dis; 2019 Nov; 72(6):374-380. PubMed ID: 31257246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
    Teto G; Tagny CT; Mbanya D; Fonsah JY; Fokam J; Nchindap E; Kenmogne L; Njamnshi AK; Kanmogne GD
    Sci Rep; 2017 Oct; 7(1):14136. PubMed ID: 29074854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa.
    Farinre O; Gounder K; Reddy T; Tongo M; Hare J; Chaplin B; Gilmour J; Kanki P; Mann JK; Ndung'u T
    Retrovirology; 2021 May; 18(1):11. PubMed ID: 33952315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.
    Kinloch NN; Lee GQ; Carlson JM; Jin SW; Brumme CJ; Byakwaga H; Muzoora C; Bwana MB; Cobarrubias KD; Hunt PW; Martin JN; Carrington M; Bangsberg DR; Harrigan PR; Brockman MA; Brumme ZL
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of individual's T-cell immunome in controlling HIV-1 progression.
    Grifoni A; Montesano C; Palma P; Giovanetti M; Castelli-Gattinara G; Ciccozzi M; Mattei M; Mancino G; Salerno A; Colizzi V; Amicosante M
    Immunology; 2014 Dec; 143(4):631-9. PubMed ID: 24954875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strong association of human leukocyte antigen-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection.
    Van Tran G; Chikata T; Carlson JM; Murakoshi H; Nguyen DH; Tamura Y; Akahoshi T; Kuse N; Sakai K; Sakai S; Cobarrubias K; Oka S; Brumme ZL; Van Nguyen K; Takiguchi M;
    AIDS; 2016 Mar; 30(5):681-9. PubMed ID: 26595539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen-associated gag and nef polymorphisms in HIV-1 subtype A/E-infected individuals in Vietnam.
    Takahashi N; Matsuoka S; Thi Minh TT; Ba HP; Naruse TK; Kimura A; Shiino T; Kawana-Tachikawa A; Ishikawa K; Matano T; Nguyen Thi LA
    Microbes Infect; 2019 Mar; 21(2):113-118. PubMed ID: 30385305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.
    Rolland M; Carlson JM; Manocheewa S; Swain JV; Lanxon-Cookson E; Deng W; Rousseau CM; Raugi DN; Learn GH; Maust BS; Coovadia H; Ndung'u T; Goulder PJ; Walker BD; Brander C; Heckerman DE; Mullins JI
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG.
    Fischetti L; Opare-Sem O; Candotti D; Sarkodie F; Lee H; Allain JP
    J Med Virol; 2004 Jun; 73(2):158-66. PubMed ID: 15122787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.
    Gounder K; Padayachi N; Mann JK; Radebe M; Mokgoro M; van der Stok M; Mkhize L; Mncube Z; Jaggernath M; Reddy T; Walker BD; Ndung'u T
    PLoS One; 2015; 10(3):e0119886. PubMed ID: 25781986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort.
    Peters HO; Mendoza MG; Capina RE; Luo M; Mao X; Gubbins M; Nagelkerke NJ; Macarthur I; Sheardown BB; Kimani J; Wachihi C; Thavaneswaran S; Plummer FA
    J Virol; 2008 Feb; 82(4):1980-92. PubMed ID: 18057233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development.
    Tongo M; Zembe L; Ebong E; Roux S; Bekker LG; Williamson C; Mpoudi-Ngole E; Burgers WA
    Vaccine; 2014 Apr; 32(20):2328-36. PubMed ID: 24598726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG.
    Ojesina AI; Chaplin B; Sankalé JL; Murphy R; Idigbe E; Adewole I; Ekong E; Idoko J; Kanki PJ
    AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1167-74. PubMed ID: 18729771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
    Saina MC; Bi X; Lihana R; Lwembe R; Ishizaki A; Panikulam A; Palakudy T; Musoke R; Owens M; Songok EM; Ichimura H
    PLoS One; 2015; 10(8):e0137140. PubMed ID: 26317223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential immune escape mutations under inferred selection pressure in HIV-1 strains circulating in Medellín, Colombia.
    Arcia D; Ochoa R; Hernández JC; Álvarez CM; Díaz FJ; Velilla PA; Acevedo-Sáenz L
    Infect Genet Evol; 2019 Apr; 69():267-278. PubMed ID: 30808498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.